Skip to main content

Or 34,00 After 66% tax deduction

I make a monthly donation I make an IFI donation
Research, science & health

Transcranial direct current stimulation: benefits for treatment of primary progressive aphasia

Published on: 16/12/2016 Reading time: 1 min
aphp

Transcranial direct current stimulation could be beneficial in treating primary progressive aphasia. This is what a pre-therapeutic study recently showed, conducted by teams led by Dr. Marc Teichmann, from the Pitié-Salpêtrière AP-HP Hospital neurology department, and Antoni Valero-Cabré, research director at the French Scientific Research Center (CNRS), both at Paris Brain Institute.

Primary progressive aphasia (PPA) is a degenerative illness characterized by progressive loss of language abilities. The most common form of PPA, known as “semantic”, is defined by progressive loss of the ability to process concepts and meaning of words.

Currently, there is no confirmed treatment for aphasia independently from its origin (degenerative or post-stroke). Studies up until now were conducted on small samples (often fewer than 6 patients) or individual case studies, complicating interpretation of results.

Dr. Marc Teichmann, from the Pitié-Salpêtrière AP-HP Hospital neurology department, and Antoni Valero-Cabré, research director at the French Scientific Research Center (CNRS), both at the Institut du Cerveau - ICM, coordinated a study of twelve patients with semantic PPA. Thorough double-blind placebo-controlled methodology allowed the evaluation of transcranial direct current simulation (tDCS) effects on language and semantic skills.
tDCS is a non-invasive stimulation involving low intensity direct current that flows thanks to two electrodes places on the scalp. It does not generate any specific sensation on the stimulated area, meaning that neither patients nor doctors can differentiate active stimulation from a placebo.

Short-term clinical effects of three kinds of stimulation (anterior left temporal cortex anodal excitation; anterior right temporal cortex cathodal inhibition; placebo stimulation) were evaluated during three sessions with a week in between each session. The effects of the three forms of stimulation were then compared.

Stimulation effect was evaluated using a multidimensional semantic test. Pre/post stimulation contrast analysis, which compared left and right tDCS to placebo stimulation, demonstrated several significant effects: improved verbal semantic performance function and improved function specifically for the “living things” category. A computational model, taking into account electrode location and conductivity of the various layers of tissue (from scalp to cerebral cortex), demonstrated optimized focality of the procedure on the anterior region of the temporal lobe and efficacy of the current delivered from the scalp to the targeted cortex.

It is noteworthy that tDCS is less costly and easier to use than other non-invasive brain modulation methods such as transcranial magnetic stimulation (TMS).
This pre-therapeutic study opens up new opportunities for developing clinical applications with more durable effects for patients with degenerative aphasia. A therapeutic protocol using repeated stimulation for 10 days to induce a months-long effect with neuroplasticity mechanisms was developed and recently received AP-HP promotion. If the procedure of consecutive stimulation for several days proves useful, it can be repeated as soon as benefits begin to decrease.

In the near future, treatments using stimulation could be tailored to cranial perimeters, lesion load and distribution of individual patients, to optimize stimulation for significant and durable therapeutic effects for everyone.

Sources

https://onlinelibrary.wiley.com/doi/10.1002/ana.24766/full
Teichmann M, Lesoil C, Godard J, Vernet M, Bertrand A, Levy R, Dubois B, Lemoine L, Truong DQ, Bikson M, Kas A, Valero-Cabré A. Ann Neurol. 2016 Sep 19.

Our news on the subject

Le développement du cerveau a une part d’aléatoire
The stochastic aspect of brain development
Although every person’s personality is the result of genetic and environmental factors, these are not the only factors at play. Bassem Hassan and his team at Paris Brain Institute have discovered that, in fruit flies (drosophila), individuality also...
05.12.2025 Research, science & health
Analyse MERSCOPE
New treatment pathways for brain malformation-linked focal epilepsy?
A study by Stéphanie Baulac’s team has revealed somatic mutations in different cell types in patients with type 2 focal cortical dysplasia. This disease causes drug-resistant epileptic seizures, for which the main treatment option is currently...
05.12.2025 Research, science & health
Un iceberg
The ICEBERG cohort, 10 years of collective scientific and medical mobilization
The ICEBERG cohort, initiated 10 years ago, is interested in studying factors predictive of the onset and progression of Parkinson’s disease.
05.15.2025 Research, science & health
La huntingtine est une protéine indispensable au développement embryonnaire, à la formation et au maintien du tissu cérébral.
Huntington's Disease: The Energy Hypothesis Gets Traction
Huntington's disease, a rare hereditary neurological disorder, is associated with an energy deficit that precedes the onset of symptoms and is closely linked to their progression. At Paris Brain Institute, Fanny Mochel and her colleagues are testing...
02.11.2025 Research, science & health
À la recherche de marqueurs d’imagerie dans la démence frontotemporale
Searching for Imaging Markers in Frontotemporal Dementia
Could exploring the relationships between different brain networks help us understand frontotemporal dementia (FTD)? This neurodegenerative disease, which progresses at varying rates, is often diagnosed late—when clinical signs are already severe. At...
01.07.2025 Research, science & health
Monocyte – un globule blanc qui se différencie en macrophage. Crédit : Université d’Edinbourg.
Discovery of a Macrophage Anomaly in Multiple Sclerosis
Certain patients with multiple sclerosis (MS) can partially regenerate myelin—the protective sheath that surrounds nerve fibers—which is damaged during the evolution of the disease. In studying how immune cells influence this remyelination...
12.19.2024 Research, science & health
See all our news